Injury Care Medical Center, Boise, ID, USA.
Analgesic Solutions, Natick, MA, USA.
J Pain Res. 2014 Dec 9;7:727-35. doi: 10.2147/JPR.S63118. eCollection 2014.
Treatment for pain due to shoulder impingement syndrome (SIS) typically begins conservatively with nonsteroidal anti-inflammatory drugs and physical therapy and can include subacromial injection of corticosteroids, particularly in patients unresponsive to conservative measures. The heated lidocaine/tetracaine (HLT) patch has been reported to reduce SIS pain in a small case series.
This was a prospective, randomized, open-label clinical trial in which adult patients with SIS pain lasting at least 14 days, with an average intensity of ≥4 on a 0-10 scale (0= no pain, 10= worst pain) were randomized to treatment with the HLT patch or a single subacromial injection of triamcinolone acetonide (10 mg). Patients in the HLT patch group applied a single HLT patch to the shoulder for 4 hours twice daily, with a 12-hour interval between treatments during the first 14 days, and could continue to use the patch on an as-needed basis (up to twice daily) during the second 14-day period. No treatment was allowed in the final 14-day period. At baseline and at days 14, 28, and 42, patients rated their pain and pain interference with specific activities (0-10 scale).
Sixty patients enrolled in the study (average age =51 years, range 18-75, n=21 female). Average pain scores declined from 6.0±1.6 at baseline to 3.5±2.4 at day 42 in the HLT patch group (n=29, P<0.001) and from 5.6±1.2 to 3.2±2.6 in the injection group (n=31, P<0.001). Similar improvements were seen in each group for worst pain; pain interference with general activity, work, or sleep; and range of motion. No significant between-group differences were seen for any pain or pain interference scores at any time point.
These results suggest that short-term, noninvasive treatment with the HLT patch has similar efficacy to subacromial corticosteroid injections for the treatment of pain associated with SIS.
治疗肩峰下撞击综合征(SIS)引起的疼痛通常从非甾体抗炎药和物理治疗开始保守治疗,如果对保守治疗无反应,可以包括肩峰下皮质类固醇注射,特别是在患者中。已报道加热的利多卡因/丁卡因(HLT)贴剂可减少小病例系列中的 SIS 疼痛。
这是一项前瞻性、随机、开放性临床试验,其中患有 SIS 疼痛至少 14 天的成年患者,平均强度≥4(0-10 级,0=无疼痛,10=最疼痛),随机分为 HLT 贴剂或单次肩峰下曲安奈德注射治疗。HLT 贴剂组的患者每天两次将单个 HLT 贴剂应用于肩部 4 小时,在第一个 14 天内,两次治疗之间间隔 12 小时,在第二个 14 天期间可以按需(每天最多两次)继续使用贴剂。在最后 14 天内不允许进行任何治疗。在基线和第 14、28 和 42 天,患者对其疼痛和疼痛对特定活动的干扰程度(0-10 级)进行了评分。
共有 60 名患者入组研究(平均年龄=51 岁,范围 18-75 岁,n=21 名女性)。HLT 贴剂组的平均疼痛评分从基线时的 6.0±1.6 下降到第 42 天的 3.5±2.4(n=29,P<0.001),从 5.6±1.2 下降到注射组的 3.2±2.6(n=31,P<0.001)。在每个组中,最严重疼痛、一般活动、工作或睡眠疼痛干扰以及运动范围都有类似的改善。在任何时间点,两组之间的任何疼痛或疼痛干扰评分均无显着差异。
这些结果表明,HLT 贴剂的短期非侵入性治疗与肩峰下皮质类固醇注射治疗 SIS 相关疼痛具有相似的疗效。